Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uterine Cervical Neoplasms | 3 | 2025 | 266 | 0.770 |
Why?
|
| Glioblastoma | 2 | 2023 | 372 | 0.670 |
Why?
|
| Brain Neoplasms | 3 | 2023 | 1306 | 0.550 |
Why?
|
| Glioma | 1 | 2022 | 495 | 0.500 |
Why?
|
| Registries | 10 | 2025 | 1608 | 0.410 |
Why?
|
| Astrocytoma | 2 | 2023 | 101 | 0.340 |
Why?
|
| Russia | 4 | 2023 | 38 | 0.250 |
Why?
|
| Immunological Synapses | 1 | 2026 | 32 | 0.230 |
Why?
|
| Incidence | 4 | 2022 | 3314 | 0.230 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2023 | 747 | 0.220 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2025 | 107 | 0.220 |
Why?
|
| Adenocarcinoma | 2 | 2023 | 968 | 0.200 |
Why?
|
| Time-to-Treatment | 1 | 2025 | 208 | 0.200 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2025 | 239 | 0.200 |
Why?
|
| Hutchinson's Melanotic Freckle | 1 | 2022 | 4 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2026 | 499 | 0.180 |
Why?
|
| Ovarian Neoplasms | 1 | 2025 | 421 | 0.170 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 2601 | 0.170 |
Why?
|
| Neuroendocrine Tumors | 1 | 2022 | 70 | 0.170 |
Why?
|
| Carcinoma | 1 | 2022 | 283 | 0.150 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2026 | 609 | 0.150 |
Why?
|
| Esophageal Neoplasms | 1 | 2023 | 384 | 0.140 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 314 | 0.140 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2026 | 949 | 0.140 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 169 | 0.130 |
Why?
|
| Adult | 9 | 2025 | 31012 | 0.120 |
Why?
|
| Pancreatic Neoplasms | 1 | 2022 | 735 | 0.120 |
Why?
|
| Survival Rate | 2 | 2018 | 2110 | 0.120 |
Why?
|
| Melanoma | 1 | 2022 | 927 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2022 | 903 | 0.110 |
Why?
|
| Humans | 16 | 2026 | 130071 | 0.100 |
Why?
|
| Neoplasms | 2 | 2019 | 2980 | 0.100 |
Why?
|
| Hepatitis B | 1 | 2013 | 170 | 0.090 |
Why?
|
| Germany | 2 | 2022 | 58 | 0.080 |
Why?
|
| Europe | 2 | 2022 | 360 | 0.080 |
Why?
|
| Female | 7 | 2025 | 70243 | 0.080 |
Why?
|
| Young Adult | 3 | 2022 | 9981 | 0.080 |
Why?
|
| Global Health | 2 | 2025 | 622 | 0.070 |
Why?
|
| Hepatitis C | 1 | 2013 | 376 | 0.070 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 416 | 0.070 |
Why?
|
| Aged | 4 | 2025 | 20818 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2018 | 5038 | 0.070 |
Why?
|
| Middle Aged | 4 | 2025 | 28305 | 0.060 |
Why?
|
| CD3 Complex | 1 | 2026 | 95 | 0.060 |
Why?
|
| Skin Transplantation | 1 | 2025 | 56 | 0.060 |
Why?
|
| Adoptive Transfer | 1 | 2025 | 235 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2013 | 976 | 0.050 |
Why?
|
| Europe, Eastern | 1 | 2023 | 1 | 0.050 |
Why?
|
| Asia, Central | 1 | 2023 | 2 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2025 | 668 | 0.050 |
Why?
|
| Graft Survival | 1 | 2025 | 462 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2026 | 393 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2025 | 373 | 0.050 |
Why?
|
| Gene Editing | 1 | 2025 | 236 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2025 | 460 | 0.050 |
Why?
|
| Taiwan | 1 | 2022 | 38 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 1367 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 316 | 0.050 |
Why?
|
| Australia | 1 | 2022 | 170 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2025 | 1278 | 0.040 |
Why?
|
| Mammography | 1 | 2022 | 121 | 0.040 |
Why?
|
| Breast | 1 | 2022 | 213 | 0.040 |
Why?
|
| Male | 3 | 2022 | 64375 | 0.040 |
Why?
|
| USSR | 1 | 2019 | 4 | 0.040 |
Why?
|
| Mice | 2 | 2026 | 18153 | 0.040 |
Why?
|
| Age Distribution | 1 | 2019 | 421 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2026 | 3713 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2026 | 1707 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 1228 | 0.030 |
Why?
|
| Mass Screening | 1 | 2022 | 817 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2018 | 393 | 0.030 |
Why?
|
| Animals | 2 | 2026 | 33660 | 0.030 |
Why?
|
| Adolescent | 2 | 2023 | 20800 | 0.030 |
Why?
|
| Arctic Regions | 1 | 2013 | 5 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2026 | 4645 | 0.020 |
Why?
|
| Child | 2 | 2022 | 26173 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 1069 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6169 | 0.020 |
Why?
|
| Infant | 1 | 2023 | 13262 | 0.020 |
Why?
|
| United States | 1 | 2022 | 11890 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 3025 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6763 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 17541 | 0.010 |
Why?
|